The authors acknowledge the support provided by US National Institutes of Health grants R01AG051944, R01AG026364, R01CA160245 and R01CA207130, Max Kade Foundation, and the Cousins Center for Psychoneuroimmunology. 1. Institute for… Click to show full abstract
The authors acknowledge the support provided by US National Institutes of Health grants R01AG051944, R01AG026364, R01CA160245 and R01CA207130, Max Kade Foundation, and the Cousins Center for Psychoneuroimmunology. 1. Institute for Medicine. Preventing mental, emotional, and behavioral disorders among young people: progress and possibilities. Washington: National Academy Press, 2009. 2. Irwin MR. Annu Rev Psychol 2015;66:143-72. 3. Cho HJ, Lavretsky H, Olmstead R et al. Am J Psychiatry 2008;165:1543-50. 4. Irwin MR, Olmstead R, Carroll JE. Biol Psychiatry 2016;80:40-52. 5. Slavich GM, IrwinMR. Psychol Bull 2014;140:774-815. 6. Irwin MR, OppMR. Neuropsychopharmacology 2017;42:129-55. 7. Dantzer R. Biol Psychiatry 2012;71:4-5. 8. Irwin MR, Cole SW. Nature Rev Immunol 2011;11:625-32. 9. Irwin MR, Olmstead R, Carrillo C et al. J Clin Oncol 2017;35:2656-65.
               
Click one of the above tabs to view related content.